Khiron Life Sciences Performance

KHRWFDelisted Stock  USD 0  0.00  0.00%   
The company secures a Beta (Market Risk) of -28.79, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Khiron Life are expected to decrease by larger amounts. On the other hand, during market turmoil, Khiron Life is expected to outperform it. Khiron Life Sciences right now secures a risk of 0.0%. Please verify Khiron Life Sciences sortino ratio, as well as the relationship between the downside variance and rate of daily change , to decide if Khiron Life Sciences will be following its current price movements.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Khiron Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Khiron Life is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow21.6 M
  

Khiron Life Relative Risk vs. Return Landscape

If you would invest  0.41  in Khiron Life Sciences on January 26, 2024 and sell it today you would earn a total of  0.00  from holding Khiron Life Sciences or generate 0.0% return on investment over 90 days. Khiron Life Sciences is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Khiron, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  

Khiron Life Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Khiron Life's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Khiron Life Sciences, and traders can use it to determine the average amount a Khiron Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
KHRWF
Based on monthly moving average Khiron Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Khiron Life by adding Khiron Life to a well-diversified portfolio.

Khiron Life Fundamentals Growth

Khiron Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Khiron Life, and Khiron Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Khiron Pink Sheet performance.

About Khiron Life Performance

To evaluate Khiron Life Sciences Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Khiron Life generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Khiron Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Khiron Life Sciences market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Khiron's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada. Khiron Life is traded on OTC Exchange in the United States.

Things to note about Khiron Life Sciences performance evaluation

Checking the ongoing alerts about Khiron Life for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Khiron Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Khiron Life Sciences is not yet fully synchronised with the market data
Khiron Life Sciences has some characteristics of a very speculative penny stock
Khiron Life Sciences has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 12.79 M. Net Loss for the year was (33.13 M) with profit before overhead, payroll, taxes, and interest of 0.
Khiron Life generates negative cash flow from operations
Latest headline from barrons.com: JPMorgan Loses Multiple Former First Republic Advisor Teams With More Than 13 Billion in Assets
Evaluating Khiron Life's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Khiron Life's pink sheet performance include:
  • Analyzing Khiron Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Khiron Life's stock is overvalued or undervalued compared to its peers.
  • Examining Khiron Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Khiron Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Khiron Life's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Khiron Life's pink sheet. These opinions can provide insight into Khiron Life's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Khiron Life's pink sheet performance is not an exact science, and many factors can impact Khiron Life's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Consideration for investing in Khiron Pink Sheet

If you are still planning to invest in Khiron Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Khiron Life's history and understand the potential risks before investing.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stocks Directory
Find actively traded stocks across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world